Two new classes of experimental drugs shown to have powerful muscle-building capabilities–selective androgen receptor modulators (SARMs) and myostatin inhibitors–have been added to the World Anti-Doping Agency’s (WADA) list of prohibited substances for 2008.

Unlike with testosterone and other anabolic steroids, the action of SARMs and myostatin inhibitors is restricted to muscle, likely limiting side effects.